- Home
- EDSA vs ABTS Comparison
EDSA vs ABTS Comparison
Compare EDSA & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- ABTS
- Stock Information
- Founded
- EDSA 2015
- ABTS 2010
- Country
- EDSA Canada
- ABTS Hong Kong
- Employees
- EDSA N/A
- ABTS N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- EDSA Health Care
- ABTS Technology
- Exchange
- EDSA Nasdaq
- ABTS Nasdaq
- Market Cap
- EDSA 6.1M
- ABTS 16.0M
- IPO Year
- EDSA N/A
- ABTS N/A
- Fundamental
- Price
- EDSA $1.73
- ABTS $0.46
- Analyst Decision
- EDSA Strong Buy
- ABTS
- Analyst Count
- EDSA 1
- ABTS 0
- Target Price
- EDSA $21.00
- ABTS N/A
- AVG Volume (30 Days)
- EDSA 30.8K
- ABTS 89.5K
- Earning Date
- EDSA 02-07-2025
- ABTS 12-31-2024
- Dividend Yield
- EDSA N/A
- ABTS N/A
- EPS Growth
- EDSA N/A
- ABTS N/A
- EPS
- EDSA N/A
- ABTS N/A
- Revenue
- EDSA N/A
- ABTS $5,343,888.00
- Revenue This Year
- EDSA N/A
- ABTS N/A
- Revenue Next Year
- EDSA N/A
- ABTS N/A
- P/E Ratio
- EDSA N/A
- ABTS N/A
- Revenue Growth
- EDSA N/A
- ABTS 3970.67
- 52 Week Low
- EDSA $1.55
- ABTS $0.38
- 52 Week High
- EDSA $5.99
- ABTS $1.60
- Technical
- Relative Strength Index (RSI)
- EDSA 31.51
- ABTS 40.47
- Support Level
- EDSA $1.73
- ABTS $0.41
- Resistance Level
- EDSA $1.99
- ABTS $0.58
- Average True Range (ATR)
- EDSA 0.19
- ABTS 0.07
- MACD
- EDSA 0.02
- ABTS -0.02
- Stochastic Oscillator
- EDSA 18.00
- ABTS 14.52
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.